Migraine statistics in the US show about 16% of adults, or more than 42 million people, report migraine or severe headache, including 21% of women and 10.7% of men, according to national health survey data. Studies using strict diagnostic criteria find women are about three times as likely as men to have migraine, migraine causes about 4 million emergency department visits a year, and its economic burden is estimated at more than $78 billion annually.
Migraine in US 2026 – Introduction
Migraine is a neurological disease, not just a bad headache. Attacks bring throbbing pain, nausea and sensitivity to light and sound, and they can last from 4 to 72 hours. In the United States, migraine ranks among the leading causes of disability, and it is the top cause of disability for women ages 15 to 49. Migraine statistics also show a large gap between women and men that appears after puberty.
This report covers prevalence, differences between women and men, age and ethnicity, hormones across a woman’s life, symptoms, treatments, healthcare use and cost. It uses survey and guideline data from the National Health Interview Survey, the American College of Physicians, the American Migraine Foundation and published studies. This report is general information, not medical advice, and anyone with frequent or severe headaches should talk to a clinician. Several figures come from earlier studies, and the report gives each source’s year where known.
Interesting Facts about Migraine in US 2026
SHARE OF US ADULTS REPORTING MIGRAINE OR SEVERE HEADACHE (percent, NHIS)
All adults | ████████████████ 16.0
Women | █████████████████████ 21.0
Men | ███████████ 10.7
Ages 30-49 | ██████████████████████ 22.1
Hispanics | ████████████████ 16.0
| Fact | US Data |
|---|---|
| Adults reporting migraine or severe headache | 16% (more than 42 million) |
| Women | 21% (about 1 in 5) |
| Men | 10.7% (about 1 in 10) |
| Adults ages 30–49 | 22.1% |
| Hispanic adults | 16.0% |
| Migraine prevalence, clinical-criteria studies | 11.7% to 14.7% |
| Women in those studies | 17.1% to 19.2% |
| Men in those studies | 5.6% to 7.2% |
| Emergency department visits a year | About 4 million |
| Economic burden (medical costs and lost productivity) | More than $78 billion a year |
Source: Coalition for Headache and Migraine Patients (CHAMP) Headache Diseases Statistics Guide, using National Health Interview Survey data; American College of Physicians guideline (Annals of Internal Medicine); Icahn School of Medicine at Mount Sinai systematic review; American Migraine Foundation.
About 16% of American adults say they have had migraine or severe headache, which is more than 42 million people. The rate is 21% for women and 10.7% for men. Adults ages 30 to 49 have the highest rate, at 22.1%. These survey numbers count migraine and severe headache together, so they run higher than studies that apply strict diagnostic criteria.
Studies using clinical criteria find 11.7% to 14.7% of Americans have migraine, with 17.1% to 19.2% of women and 5.6% to 7.2% of men. That gap is about three to one. Migraine causes about 4 million emergency department visits a year and costs the US more than $78 billion a year in medical expenses and lost productivity, according to the American College of Physicians.
Migraine Prevalence in US 2026: How Many Americans Have Migraine
ESTIMATES OF PEOPLE WITH MIGRAINE IN THE US (millions)
NHIS migraine or severe headache, adults | ███████████████████ 42+
American Migraine Foundation estimate | █████████████████ 40+
Global Burden of Disease, 2021 | ██████████████████████████████ 57.7
| Measure | Estimate |
|---|---|
| Adults with migraine or severe headache (NHIS) | 16%, more than 42 million |
| NHIS 2018 update | 15.9% of adults |
| Clinical-criteria studies, past 30 years | 11.7% to 14.7% |
| American Migraine Foundation | More than 40 million Americans |
| Global Burden of Disease, 2021 | About 57.7 million |
| Chronic migraine, adults | About 0.91% (1.3% of women, 0.5% of men) |
| Households with at least one member with migraine (older study) | 1 in 4 |
Source: CHAMP Statistics Guide; Icahn School of Medicine at Mount Sinai, systematic review of US migraine prevalence; American Migraine Foundation; JAMA Neurology Global Burden of Disease study as cited by state-level analysis; Lipton et al., 2000-2007.
Estimates differ by what is counted. The National Health Interview Survey asks adults whether they have had migraine or a severe headache in the past three months, and 16% say yes. A review of US studies over 30 years found a steady range of 11.7% to 14.7% when clinical criteria were used. The American Migraine Foundation says more than 40 million Americans have migraine, and a Global Burden of Disease study put the count at 57.7 million in 2021.
Chronic migraine is much rarer. About 0.91% of adults have it, including 1.3% of women and 0.5% of men, according to the Mount Sinai review. Chronic migraine means headache on at least 15 days a month, with at least 8 days of full migraine attacks. An older household study found migraine in about 1 in 4 US households. The range across sources shows why a single number is not definitive.
Migraine in Women vs Men US 2026: The Gender Gap in Numbers
MIGRAINE PREVALENCE BY SEX (percent)
Women, NHIS migraine/severe headache | █████████████████████ 21.0
Men, NHIS migraine/severe headache | ███████████ 10.7
Women, clinical studies (high end) | ███████████████████ 19.2
Men, clinical studies (high end) | ███████ 7.2
Chronic migraine, women | █ 1.3
Chronic migraine, men | 0.5
| Measure | Women | Men |
|---|---|---|
| NHIS migraine or severe headache | 21% | 10.7% |
| Clinical-criteria studies | 17.1% to 19.2% | 5.6% to 7.2% |
| Chronic migraine | 1.3% | 0.5% |
| Ratio after puberty | About 3 times as likely | Reference |
| Share of all people with migraine | About 75% | About 25% |
| Severe disability risk | 1.34 times higher | Reference |
| Higher disability grade (MIDAS III/IV) | A consistently higher share | Lower share |
Source: CHAMP Statistics Guide (NHIS); Icahn School of Medicine at Mount Sinai review; Society for Women’s Health Research as cited by SingleCare; Neurological Sciences (2022) as cited by SingleCare.
Women are about three times as likely as men to have migraine after puberty when clinical criteria are used. In the survey measure of migraine or severe headache, women’s rate of 21% is about twice the men’s 10.7%. The two measures differ because severe headache includes other conditions. Women make up about 75% of people with migraine, and they are 1.34 times more likely to have severe migraine-related disability.
The gap shows up in chronic migraine as well. Chronic migraine affects 1.3% of women and 0.5% of men, so women are about 2.6 times as likely to have it. A consistently higher proportion of women fall into the higher disability grades of the MIDAS scale. Researchers link the sex difference to hormones, especially estrogen, which the next sections describe. Men also have migraine, and it is often underrecognized.
Migraine by Age, Race and Ethnicity US 2026: Who Is Most Affected
MIGRAINE OR SEVERE HEADACHE BY AGE AND GROUP (percent)
Ages 30-49 | ██████████████████████ 22.1
Ages 18-44 (ACP) | ██████████████████ 18
All adults | ████████████████ 16.0
Hispanic adults | ████████████████ 16.0
| Group | Data |
|---|---|
| Adults ages 30–49 | 22.1% report migraine or severe headache |
| Adults ages 18–44 (ACP) | 18% |
| Peak prevalence | Ages 25 to 55, the peak working years |
| Hispanic adults | 16.0% |
| Black men with migraine | As many as 1.5 million |
| Indigenous Americans | More likely to report migraine or severe headache |
| Preventive prescription use | 20% of white, 10% of Hispanic, 7% of Black people with migraine |
| Unemployed adults | Disproportionately affected, per ACP |
Source: CHAMP Statistics Guide; American College of Physicians guideline; SingleCare summary citing Headache (2018, 2020) and the Journal of Racial and Ethnic Health Disparities (2025).
Migraine is most common in the prime working years. Adults ages 30 to 49 report migraine or severe headache at 22.1%, and the American College of Physicians puts adults ages 18 to 44 at 18%. Prevalence usually falls with age, and for many women it improves after menopause. The peak of 25 to 55 years is also the peak of working life, which raises the cost of lost work.
Group differences exist. Hispanic adults report 16.0%, in line with all adults. A published summary says as many as 1.5 million Black men have migraine and that Indigenous Americans are more likely to report it. A 2025 study cited there found preventive prescription medicine use of 20% among white, 10% among Hispanic and 7% among Black people with migraine, a gap that points to unequal access. This secondary source has not been checked against the study.
Hormones and Migraine in Women US 2026: Menstruation, Pregnancy and Menopause
HORMONAL PATTERNS IN WOMEN WITH MIGRAINE (percent, reported ranges)
Menstrual-related migraine (high) | ██████████████████████████ 70
Improve in pregnancy (high) | ███████████████████████████████ 80
Improve after menopause | ███████████ 33
Migraine within 2 weeks of delivery | ████████ 25
| Life Stage | Reported Data |
|---|---|
| Menstrual migraine | 60% to 70% of women with migraine (Mayo Clinic Press) |
| Menstruation as a trigger | 51% to 55% in another review |
| Pregnancy | 50% to 80% report fewer attacks |
| Second and third trimesters | About 60% to 70% notice improvement |
| Postpartum | About 25% have a migraine within two weeks; nearly half within a month |
| Menopause | About one-third report improvement |
| Avoiding pregnancy because of migraine | About 20% of women say they do |
| Typical onset | Often around the first period |
Source: Mayo Clinic Press; American Migraine Foundation; Healio clinical guidance; published CME review of perimenopause and migraine. Ranges differ across studies.
Between 60% and 70% of women with migraine have menstrual migraine, according to Mayo Clinic Press, which is linked to a drop in estrogen just before a period. Another review found 51% to 55% of women with migraine report menstruation as a trigger. Women often start having migraine around their first period, and the pattern of attacks follows hormone changes through life.
Pregnancy usually helps. Between 50% and 80% of pregnant women with migraine report fewer attacks, likely because estrogen stays high and steady. After delivery, estrogen falls, and about 25% of women have a migraine within two weeks, with nearly half having one within a month. About one-third of women report improvement after menopause. About 20% of women say they avoid pregnancy because of migraine.
Migraine Symptoms and Types US 2026: Duration, Aura and Chronic Migraine
MIGRAINE FEATURES (hours and share)
Typical attack length, minimum | ████ 4 hours
Typical attack length, maximum | ██████████████████████████████████████ 72 hours
People with aura | █████████████ 25%
| Feature | Detail |
|---|---|
| Attack length | 4 to 72 hours |
| Pain | Throbbing, moderate to severe |
| Common symptoms | Nausea, vomiting, sensitivity to light and sound |
| Aura | About 25% of people, before the headache |
| Episodic migraine | 1 to 14 headache days per month |
| Chronic migraine | At least 15 headache days a month, 8 or more migraine days |
| Status migrainosus | Attack lasting more than 72 hours |
| Diagnosis | Based on history and exam; no biological marker |
| Menstrual migraine types | Pure menstrual and menstrually related |
Source: Clinical trial protocols citing the International Classification of Headache Disorders (ICHD-3); American College of Physicians; Mayo Clinic Press.
Migraine attacks last 4 to 72 hours and bring throbbing, moderate to severe pain, often with nausea, vomiting and sensitivity to light and sound. About 25% of people have an aura before the headache. Episodic migraine means 1 to 14 headache days a month, and chronic migraine means at least 15, with at least 8 full migraine days. Each year, about 1 million people with episodic migraine move to chronic migraine, according to older estimates.
There is no biological test, so doctors diagnose migraine from a history and exam and rule out other causes. Status migrainosus, an attack of more than 72 hours, needs medical attention. Menstrual migraine falls into two types: pure menstrual, which comes only around periods, and menstrually related, which also occurs at other times. Anyone with a sudden, severe or unusual headache should seek care promptly.
Migraine Treatments in US 2026: Acute, Preventive and CGRP Medicines
MEDIAN ANNUAL COST OF NEWER CGRP PREVENTIVE TREATMENTS (US dollars)
Low end of range | ███████████████ 7,071
High end of range | ██████████████████████████████████████████████████ 22,790
| Treatment Type | Examples and Data |
|---|---|
| Acute treatments | Triptans, gepants (ubrogepant, rimegepant), lasmiditan, celecoxib solution |
| Preventive medicines, older | Propranolol, topiramate, valproate |
| Preventive CGRP antibodies | Erenumab, fremanezumab, galcanezumab, eptinezumab |
| Preventive gepants | Atogepant, rimegepant |
| Procedure-type preventive | OnabotulinumtoxinA for chronic migraine |
| Median annual cost, newer CGRP therapies | $7,071 to $22,790 |
| ACP guideline approach | Suggests monotherapy and lower-cost first options for episodic migraine prevention |
| Pregnancy | CGRP antibodies not recommended; others vary |
| Preventive treatment use | Only a small percentage of eligible people |
Source: American College of Physicians guideline (Annals of Internal Medicine); American Headache Society consensus statement; Healio clinical guidance; Mayo Clinic Press. This report does not give dosing or personal medical advice.
Treatment has two parts: acute medicines taken during an attack and preventive medicines taken regularly. Acute options include triptans and newer drugs such as gepants and lasmiditan. Preventive options include propranolol, topiramate and valproate, newer CGRP antibodies and the gepants atogepant and rimegepant, and onabotulinumtoxinA for chronic migraine. Median annual cost of the newer CGRP therapies ranges from $7,071 to $22,790.
The American College of Physicians guideline suggests lower-cost options first for episodic migraine prevention in non-pregnant adults, and monotherapy rather than combinations. It says migraine is underdiagnosed and undertreated, with only a small percentage of eligible people getting preventive medicine. Choices depend on age, other health conditions and pregnancy, so decisions belong to a clinician. CGRP antibodies are not recommended during pregnancy, according to clinical guidance.
Migraine Emergency Visits, Office Visits and Costs US 2026: The Healthcare Burden
MIGRAINE HEALTHCARE USE PER YEAR (millions of visits)
Emergency department visits | ████████████████████████████████████████ 4.0
Office visits | ███████████████████████████████████████████ 4.3
| Measure | Data |
|---|---|
| Emergency department visits | About 4 million a year (2016 data) |
| Office visits | More than 4.3 million a year |
| Economic burden, ACP | More than $78 billion a year |
| Lower estimate (AJMC, 2020) | About $19.3 billion in lost productivity |
| Older estimate | More than $56 billion a year |
| Extra healthcare spending per person with migraine | About $6,000 a year |
| Chronic migraine and work | About a quarter of workdays at 50% capacity or less |
| Share of facility visits in primary care | More than half |
Source: American College of Physicians guideline; Journal of Managed Care and Specialty Pharmacy (2024) and American Journal of Managed Care (2020) as cited by SingleCare; Postgraduate Medicine review of acute treatment.
Migraine sends about 4 million people to emergency departments a year and accounts for more than 4.3 million office visits, with more than half of facility visits in primary care. The ED figure is from 2016 data. People with migraine spend about $6,000 more a year on healthcare than people without it, according to a 2024 study cited by SingleCare.
Cost estimates range widely because they count different things. The American College of Physicians cites more than $78 billion a year in medical expenses and lost productivity, while an AJMC study put lost productivity alone at about $19.3 billion. An older review gave more than $56 billion. People with chronic migraine spend about a quarter of their workdays at 50% capacity or less. All of these estimates are approximate.
Migraine Disability and Work Impact US 2026: Lost Days and Productivity
MIGRAINE DISABILITY AND WORK MEASURES
Bed-rest days per year, women (older estimate) | ██████████████████████████ 5.6
Bed-rest days per year, men (older estimate) | ██████████████████ 3.8
| Measure | Data |
|---|---|
| Global rank among causes of disability | Second leading cause |
| Rank for females ages 15 to 49 | Leading cause |
| Chronic migraine and work | About one-quarter of workdays at 50% capacity or less |
| Bed-rest days per year (older estimate) | 5.6 for women, 3.8 for men |
| Total bed-rest days (older estimate) | About 112 million a year |
| Work loss cost (1999 estimate) | About $13 billion a year |
| Depression and anxiety risk (SingleCare summary) | About three times higher |
| Peak working-age prevalence | Ages 25 to 55 |
Source: American College of Physicians guideline; Postgraduate Medicine review; patent-literature summary of 1990s US estimates; SingleCare summary of published studies. Older estimates are labeled and may not reflect today.
Migraine is the second leading cause of disability worldwide and the leading cause among females ages 15 to 49. People with chronic migraine spend about a quarter of their workdays at half capacity or less. Older estimates from the 1990s put bed rest at 5.6 days a year for women and 3.8 for men, about 112 million days in total, and work loss at about $13 billion a year.
These older numbers are dated, so they show scale, not today’s totals. A summary of published studies says people with migraine have about three times the risk of depression and anxiety, though the report did not verify the underlying studies. Because prevalence peaks at ages 25 to 55, migraine hits workers and caregivers at their busiest. Employers, insurers and clinicians all see the cost, but no single current figure covers it.
Migraine Statistics in US 2026 FAQ
How many Americans have migraine?
About 16% of adults, or more than 42 million, report migraine or severe headache. Studies using clinical criteria find 11.7% to 14.7%.
Are women more likely to have migraine than men?
Yes. About 21% of women and 10.7% of men report migraine or severe headache. Clinical studies find women about three times as likely.
What percentage of women have migraine?
About 17.1% to 19.2% in clinical studies, and 21% in national survey data.
What percentage of men have migraine?
About 5.6% to 7.2% in clinical studies, and 10.7% in national survey data.
What share of people with migraine are women?
About 75%, according to the Society for Women’s Health Research.
How long does a migraine last?
4 to 72 hours. An attack lasting more than 72 hours is called status migrainosus.
What are the symptoms of migraine?
Throbbing pain, nausea, vomiting and sensitivity to light and sound. About 25% of people also have an aura.
What is chronic migraine?
Headache on at least 15 days a month, with at least 8 days of full migraine attacks.
How common is chronic migraine?
About 0.91% of adults, including 1.3% of women and 0.5% of men.
Why are women more likely to get migraine?
Researchers link it to hormones, especially estrogen and its fluctuations, and to the pain-signaling protein CGRP.
How common is menstrual migraine?
About 60% to 70% of women with migraine experience it, per Mayo Clinic Press.
Does pregnancy help migraine?
For many women. About 50% to 80% report fewer attacks during pregnancy.
Does migraine get worse after childbirth?
It can. About 25% of women have one within two weeks of delivery.
Does menopause improve migraine?
About one-third of women report improvement, but results vary.
How many emergency room visits does migraine cause?
About 4 million a year, based on 2016 data.
How much does migraine cost the US?
More than $78 billion a year in medical expenses and lost productivity, per the American College of Physicians. Other estimates are lower.
What are CGRP treatments?
Medicines that target a pain-signaling protein, including antibodies and gepants. Median annual costs range from $7,071 to $22,790.
Is this report medical advice?
No. It is general information. Talk to a clinician about headaches or treatment.
How many workdays does chronic migraine affect?
About a quarter of workdays are at 50% capacity or less for people with chronic migraine.
Is migraine linked to depression?
A summary of published studies says people with migraine have about three times the risk of depression and anxiety.
What is the leading cause of disability for women ages 15 to 49?
Migraine, according to the American College of Physicians.
At what age is migraine most common?
Ages 30 to 49, at 22.1%, based on national survey data.
Which migraine prevention options does ACP suggest first?
The American College of Physicians guideline suggests lower-cost options first for episodic migraine prevention.
Is migraine more common in Hispanic adults?
Hispanic adults report 16.0%, about the same as all adults overall.
Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

